Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Co-Diagnostics Inc Company Overview 5

Co-Diagnostics Inc Company Snapshot 5

Co-Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Co-Diagnostics Inc – Pipeline Analysis Overview 8

Co-Diagnostics Inc - Key Facts 8

Co-Diagnostics Inc - Major Products and Services 9

Co-Diagnostics Inc Pipeline Products by Development Stage 10

Co-Diagnostics Inc Pipeline Products Overview 13

Co-Dx Test - Human Papillomavirus 13

Co-Dx Test - Human Papillomavirus Product Overview 13

Co-Dx Test - Gonorrhoea/Chlamydia 14

Co-Dx Test - Gonorrhoea/Chlamydia Product Overview 14

Companion Diagnostic Test - Cancer 15

Companion Diagnostic Test - Cancer Product Overview 15

Diagnostic Test - Drug Resistant Tuberculosis 16

Diagnostic Test - Drug Resistant Tuberculosis Product Overview 16

Diagnostic Test - Heart Disease 17

Diagnostic Test - Heart Disease Product Overview 17

Diagnostic Test - Auto-immune Disorder 18

Diagnostic Test - Auto-immune Disorder Product Overview 18

Diagnostic Test - Blood Bank Multiplex Test 19

Diagnostic Test - Blood Bank Multiplex Test Product Overview 19

Diagnostic Test - Genetic Disorder 20

Diagnostic Test - Genetic Disorder Product Overview 20

Diagnostic Test - Health Care-associated Infection 21

Diagnostic Test - Health Care-associated Infection Product Overview 21

Diagnostic Test - Hepatitis C 22

Diagnostic Test - Hepatitis C Product Overview 22

Diagnostic Test - Infectious Disease 23

Diagnostic Test - Infectious Disease Product Overview 23

Diagnostic Test - Oncology 24

Diagnostic Test - Oncology Product Overview 24

Diagnostic Test - STD Panel 25

Diagnostic Test - STD Panel Product Overview 25

Diagnostic Test - Women's Health 26

Diagnostic Test - Women's Health Product Overview 26

LightPCR 27

LightPCR Product Overview 27

Co-Diagnostics Inc - Key Competitors 28

Co-Diagnostics Inc - Key Employees 29

Co-Diagnostics Inc - Locations And Subsidiaries 30

Head Office 30

Other Locations & Subsidiaries 30

Joint Venture 30

Recent Developments 31

Co-Diagnostics Inc, Recent Developments 31

Jul 17, 2018: Co-Diagnostics Completes Submission of CE Mark Registration for Tuberculosis Screening Test 31

Jun 11, 2018: Co-Diagnostics to Host Booth at CARPHA Conference 31

Jun 05, 2018: Co-Diagnostics Announces Advancement of Co-Primers Technology in Multiplex SNP Genotyping 32

Jun 01, 2018: Co-Diagnostics Announces Participation in Research Project with Stanford University 32

Mar 22, 2018: Co-Diagnostics Announces Construction Update at JV Manufacturing Facility in India 32

Feb 28, 2018: Co-Diagnostics Announces Positive Results from Co-Primers Technology in Multiplex Tests for SNP Detection 33

Feb 21, 2018: Co-Diagnostics Ships Product to India for Validation Study 33

Dec 19, 2017: Co-Diagnostics Enters Into Lease for New, Upgraded Laboratory Facility 33

Nov 15, 2017: Co-Diagnostics Reports Q3 Financial Results and Updates Corporate Developments 34

Nov 07, 2017: Co-Diagnostics Manufacturing Joint Venture Breaks Ground in India 35

Appendix 36

Methodology 36

About GlobalData 39

Contact Us 39

Disclaimer 39

Summary

Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit. Its products finds application in window period detection in blood screening, viral load for monitoring the success of treatment, and infant diagnosis for detecting disease in infants, among others. The company’s technologies comprise Co-Dx, a suite of mathematically-engineered DNA-based polymerase chain reaction diagnostics products, and Adaptivex which helps primers address the challenge of unexpected mutations. Its technology is designed for new generation mobile point-of-care diagnostic devices, and commercially available devices. Co-Diagnostics is headquartered in Sandy, Utah, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Co-Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company